default author photo

Udo Lindig

affiliation not provided to SSRN

  • affiliation not provided to SSRN

SCHOLARLY PAPERS

1

DOWNLOADS

32

TOTAL CITATIONS

0

Scholarly Papers (1)

Actions:
Email selected abstracts
1.

Nivolumab in combination with lenvatinib in advanced hepatocellular carcinoma: the IKF-t006/IMMUNIB translational phase-2 study  NCT03841201

Number of pages: 27 Posted: 05 May 2026
Arndt Vogel, Najib Ben Khaled, Javier Ramirez, Garbiele Siebler, Jürgen Siebler, Udo Lindig, Silke Marhenke, Gregory Schwartz, Micheal Schultheiss, Tobias Mueller, Henry Simon, Enrico N. De Toni, Daniel Karl, Salah-Eddin Al-Batran and Anna Saborowski
Hannover Medical School - Department of Gastroenterology, Hepatology and Endocrinology, Technische Universität München (TUM) - Institute of Molecular Oncology and Functional Genomics, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, Ludwig Maximilian University of Munich (LMU), affiliation not provided to SSRN, affiliation not provided to SSRN and Hannover Medical School - Department of Gastroenterology, Hepatology and Endocrinology
Downloads 32 (1,318,317)

Abstract:

Loading...

advanced hepatocellular carcinoma, combination therapy, nivolumab, lenvatinib, 1st line